Company Information

mission

Our Mission

Save lives with
medical data.

vision

The future we are aiming for

Bringing technology to highly complexed medical sites to make data-driven decision as norm.

Medical care is supported by the dedicated efforts of frontline staff.This is what I feel standing on the front lines of medicine in the emergency room/intensive care unit.

In Japan, there is a universal health insurance system of a high level even by global standards, but behind this system lies the work of documenting the "quality of medical care provided" through a massive amount of paperwork by medical staff. As their results, a composition that epitomizes modern medicine: exhausted medical staff, patients who are frustrated by long waiting times and staff who only look at their computers.

In spite of these tough paperworks, there is no clear data existing even the the most rudimentary details such as the most common symptoms and diagnoses of patients who visit their neighboring clinics, or even what are the most common symptoms and diagnoses of the patients visiting our hospital.

To overcome such a situation, what is needed first is technology close to the field. It has been a long time since the term "Medical Al" has been in the papers, but rather than forcibly looking for situations where AI technology can be useful, we first want to solve such a situation, where paper notes are transcribed into Excel. Forcing the application of the latest IT technology to the current medical field is like trying to do a Google search on a stack of paper documents.

What the field needs is not AI technology, but first of all, a recording system that can be used as easily as paper-based operations with less double entry, and reliable clinical data that can be appropriately cross-referenced with neighboring medical institutions.

Only with such a truly useful data infrastructure in the field, Al utilization in healthcare and data-based healthcare quality assessment and policy formulation will be realized.

We are committed to building a health care system that saves lives through the approach using medical data.

Introduction of our board members

Chief Executive Officer (doctor)

Tomohiro Sonoo

Graduated from the University of Tokyo School of Medicine.Engaged mainly in clinical work in emergency intensive care at the University of Tokyo Hospital and Hitachi General Hospital.Emergency medicine specialist and intensivist.In addition to the clinical work, he has developed acute care databases and conducted several studies related to these databases.34 original papers in English (September 2020 point in time). He founded TXP Medical in August 2017, after commercializing the emergency medical information system NEXT Stage ER, which he developed by himself. He continues to actively communicate to academia and industry regarding the appropriate use of IT in the medical field.

Chief Operating Officer

Atsushi Onda

Graduated from the School of Science and Engineering, Waseda University.Worked in Accenture Strategy Group and Analytics Group on business strategy, operational reform, and big data related projects focusing on mobile, medical device, government, and energy industries. Before assuming his current position,He also worked at JMDC for developing new business and leading medical big data analysis projects, mainly for the life insurance industry and medical insurers.

Board Member

Kazuki Okuma

Graduated from School of Law, Keio University.After completing his legal training, he registered as a lawyer. He handles corporate legal matters for a wide range of industries, from startups to publicly traded companies. His strength lies in legal research for mergers and acquisitions and new services for pre- and post-listing ventures, and focuses on promoting innovative business based on the law.

Chief Scientific Officer

Tadahiro Goto

Graduated from the University of Fukui Faculty of Medicine.Trained in the Emergency Department of the same hospital. He was a core member of the Emergency Medicine Alliance and the Japanese Emergency Medicine Network.After obtaining his emergency medicine residency, he went on to complete a master's degree at Harvard School of Public Health (graduated in 2016) and three years of clinical research in the Emergency Department at Massachusetts General Hospital.After coming back to Japan, he conducted research at the University of Tokyo Graduate School of Clinical Epidemiology and Economics, and currently serves as CSO of TXP Medical, where he conducts data analysis and supervises clinical research.

Outside Board Director/ITOCHU CORPORATION
General Manager of Frontier Business Department

Tetsuya Asano

Graduated from Kyoto University, Faculty of Letters, and joined ITOCHU Corporation. After working for a system integrator, stationed in New York, seconded to a healthcare management service company, seconded to a pharmaceutical marketing company (as a director), worked as the General Manager of the Information & Telecommunication Division's Planning Supervisory Section, and served as the General Manager of the Information Industry Business Department, he assumed his current position in April 2022. Since joining the company, he has been consistently involved in business development, investment, and corporate planning in the IT and healthcare fields.

Outside Director / Principal, UTEC

Hiroaki Kobayashi

Graduated from the University of Tokyo School of Medicine. Engaged in clinical work in emergency intensive care at the University of Tokyo Hospital and other hospitals.Obtained Emergency Medicine Specialist. In 2014, he joined a medical device startup in its founding phase to promote business launches in Japan and abroad.After obtaining his Master of Business Administration (MBA) from the University of Michigan, USA in 2018, he joined UTEC in 2019 and is responsible for investments in the Life Sciences and Healthcare area.

Auditor / Director and Partner, UTEC

Noriaki Sakamoto

After graduating from the University of Tokyo, Faculty of Economics, he joined the Ministry of Economy, Trade and Industry. Retired from the Ministry of Economy, Trade and Industry (METI) in 2008. After managing a distribution business company, a family business, he earned an MBA from Columbia University, worked as a manager at McKinsey & Company, and joined UTEC in August 2014. He supported the Grand Prize and Excellence Award winning projects of NEDO TCP in 2015 and the IoT Lab Selection Grand Prix project of the Ministry of Economy, Trade and Industry in 2016, and also supported the Grand Prize in the Entrepreneurship Challenge 2017.

ADVISER

Consultant

Shinichiro Katayanagi

Graduated from the Department of Political Science, Faculty of Law, Keio University.After building a career in the overseas business sales department of Nihon Cement (now Taiheiyo Cement), he moved to Yamanouchi Pharmaceutical (now Astellas Pharma Inc.) in 1991. After working in the corporate planning and finance departments, he was stationed in Europe, where he gained experience in accounting, finance, and management system development at the European headquarters. After returning to Japan in 2001, he participated in the merger project with Fujisawa Pharmaceutical as a core member and realized the creation of the new Astellas company. After that, he was appointed General Manager of the Asia Business Division, overseeing the company's Asia-Oceania operations in 2009. In 2015, he joined Toho Holdings, a major pharmaceutical wholesaler, to lead the company's overseas business expansion as its executive officer. He joined Dainippon Sumitomo Pharma in 2016. mainly in charge of the U.S. business and in 2020 became Chairman of the U.S. subsidiary of Dainippon Sumitomo Pharma, where he oversaw operations and administration.He has been in his current position since April 2021.

Company Information

Company Name

TXP Medical Co. Ltd.

Established on

August 28, 2017.

Location

Kanda Office (Head Office)
706 H’O Kanda 41-1 Higashimatsushita-cho, Chiyoda-ku, Tokyo 101-0042

[Tokyo University Office]
Room 252, South Laboratory Ward, Tokyo University Hospital
7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8485

[Kobe Branch]
International Medical Development Center(IMDA)
1-6-5 Minatojima Minamimachi, Kobe City 650-0047

Capital

100,000,000yen (As of June 2022)

CEO

Tomohiro Sonoo, Chief Executive Officer (doctor)

Business Overview

・Development and provision of medical data systems (NEXT Stage ER series) for emergency, intensive care, and paramedical services
・Development and provision of the cancer treatment support research data system (NEXT Stage Oncology)
・Development and provision of medical AI technology
・Building a medical data platform and analyzing real-world data
・Clinical Research Support Business
・Management support and consulting services for medical institutions

Partner Companies

ALM Corporation

Collaborative Research Partners

・University of Tokyo (Structured Analysis of Pathology Reports)
・Osaka University (Department of Ophthalmology and Emergency Medicine Medical Information Recording by Voice Command)
・Yamaguchi University (Faculty of Engineering, Online Medical Treatment and Secondary Use of Medical Data to Support the Lifelong Access to Medical Care in the Western District of Japan)
・University of Miyazaki (Department of Comprehensive Medicine, Comprehensive Medicine and Medical Review)
・Hokkaido University (Department of Intensive Care, Prediction of prognosis in critically ill patients using electrocardiogram imaging data)
・Shimane University (Emergency Trauma Center, EMS Trauma Patient Transport and Disaster Response Cloud System)
・Tohoku University (Advanced Rescue Center, In-hospital emergency and doctor car applications)
・Shinshu University (Advanced Life Support Center, In-hospital Rapid Change Prediction Algorithm)